D C Brennan
Overview
Explore the profile of D C Brennan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes
Lentine K, Lam N, Naik A, Axelrod D, Zhang Z, Dharnidharka V, et al.
Am J Transplant
. 2018 Mar;
18(12):2987-2999.
PMID: 29498196
Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S. transplant registry records were linked to a large...
2.
Lentine K, Lam N, Schnitzler M, Hess G, Kasiske B, Xiao H, et al.
Am J Transplant
. 2016 Sep;
17(3):744-753.
PMID: 27589826
Implications of opioid use in living kidney donors for key outcomes, including readmission rates after nephrectomy, are unknown. We integrated Scientific Registry of Transplant Recipients data with records from a...
3.
Axelrod D, Schnitzler M, Xiao H, Naik A, Segev D, Dharnidharka V, et al.
Am J Transplant
. 2016 Aug;
17(2):377-389.
PMID: 27565133
Kidney transplantation has become more resource intensive as recipient complexity has increased and average donor quality has diminished over time. A national retrospective cohort study was performed to assess the...
4.
Gupta S, Brennan D
Transplant Proc
. 2016 Feb;
48(1):262-4.
PMID: 26915880
Background: Pneumococcal 13-valent conjugate vaccine (PCV13) is used for immunization to prevent invasive disease caused by Streptococcus pneumoniae. Rare cases of idiopathic thrombocytopenic purpura (ITP) after vaccination with PCV13 have...
5.
Lentine K, Naik A, Schnitzler M, Axelrod D, Chen J, Brennan D, et al.
Transplant Proc
. 2016 Feb;
48(1):55-8.
PMID: 26915843
Background: Modern immunosuppression therapies (ISx) have many side effects, and transplant recipients must take an array of "comedications" to help mitigate complications. Comedication use patterns are not well described in...
6.
Axelrod D, Naik A, Schnitzler M, Segev D, Dharnidharka V, Brennan D, et al.
Am J Transplant
. 2016 Feb;
16(8):2453-62.
PMID: 26901466
Immunosuppression management in kidney transplantation has evolved to include an increasingly diverse choice of medications. Although informed by patient and donor characteristics, choice of immunosuppression regimen varies widely across transplant...
7.
Alhamad T, Venkatachalam K, Linette G, Brennan D
Am J Transplant
. 2016 Jan;
16(4):1332-3.
PMID: 26752406
No abstract available.
8.
Lentine K, Lam N, Axelrod D, Schnitzler M, Garg A, Xiao H, et al.
Am J Transplant
. 2015 Dec;
16(6):1848-57.
PMID: 26700551
We integrated the US transplant registry with administrative records from an academic hospital consortium (97 centers, 2008-2012) to identify predonation comorbidity and perioperative complications captured in diagnostic, procedure, and registry...
9.
Axelrod D, Segev D, Xiao H, Schnitzler M, Brennan D, Dharnidharka V, et al.
Am J Transplant
. 2015 Nov;
16(5):1465-73.
PMID: 26603690
The infrequent use of ABO-incompatible (ABOi) kidney transplantation in the United States may reflect concern about the costs of necessary preconditioning and posttransplant care. Medicare data for 26 500 live...
10.
Brennan D, Kopetskie H, Sayre P, Alejandro R, Cagliero E, Shapiro A, et al.
Am J Transplant
. 2015 Oct;
16(2):509-17.
PMID: 26433206
We report the long-term follow-up of the efficacy and safety of islet transplantation in seven type 1 diabetic subjects from the United States enrolled in the multicenter international Edmonton Protocol...